| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.20T | 779.71B | 486.51B | 560.19B | 416.90B |
| Gross Profit | 769.90B | 445.08B | 246.03B | 319.06B | 235.91B |
| EBITDA | 526.42B | 257.13B | 108.98B | 189.08B | 129.70B |
| Net Income | 397.99B | 161.18B | 62.29B | 130.40B | 87.30B |
Balance Sheet | |||||
| Total Assets | 1.18T | 854.21B | 671.23B | 600.22B | 494.70B |
| Cash, Cash Equivalents and Short-Term Investments | 341.44B | 262.54B | 106.70B | 85.54B | 116.58B |
| Total Debt | 20.28B | 93.50B | 94.44B | 50.84B | 43.46B |
| Total Liabilities | 377.72B | 347.67B | 240.05B | 231.53B | 200.07B |
| Stockholders Equity | 799.18B | 506.54B | 431.18B | 368.69B | 294.62B |
Cash Flow | |||||
| Free Cash Flow | 320.39B | 266.54B | 12.13B | 46.64B | 60.67B |
| Operating Cash Flow | 355.40B | 285.97B | 32.67B | 70.22B | 78.89B |
| Investing Cash Flow | -36.64B | -42.19B | -27.94B | -26.71B | -46.91B |
| Financing Cash Flow | -244.45B | -82.82B | 10.76B | -77.43B | -68.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $112.51B | 30.32 | 56.56% | 0.18% | 45.93% | 136.89% | |
74 Outperform | $53.90B | 27.09 | 29.72% | 0.24% | 30.33% | 51.65% | |
72 Outperform | $43.19B | -183.45 | 7.45% | ― | -9.04% | -4.21% | |
68 Neutral | $66.12B | 26.48 | 14.45% | 2.29% | 15.55% | 43.35% | |
65 Neutral | $57.36B | 215.94 | 0.86% | 1.28% | 0.79% | -86.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $50.88B | 173.03 | 3.05% | 2.79% | 7.08% | ― |